Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesoglycan for Secondary Prevention of SVT
NCT03428711Phase 2Completed
- Sponsor
- QuoVadis
- Start
- Mar 2018
- Primary completion
- Dec 2024
- Modality
- Biologic, Polysaccharide
- Countries
- 1
01
Overview
A Phase 2 trial of mesoglycan in superficial venous thrombosis (SVT), sponsored by QuoVadis. Started Mar 2018; status: completed.
02
Drugs
mesoglycan
03
Conditions
superficial venous thrombosis (SVT)
Beyond the preview
Go deeper on NCT03428711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03428711.